(Total Views: 533)
Posted On: 09/28/2023 6:46:04 AM
Post# of 9124
The graph shows the stock price crash just over 2 years ago now when NNLX had failed to provide current financial data etc by Sept 21? 2021 to the powers that be to transition from a 'no info' otc category (which category was being eliminated) into a current reporting company.
So, we are still stuck in no mans land-the expert market -where brokers are not allowed to display bids and asks without an updated 211 form-which would require that regulators are satisfied with any updated data -of which there has been none to my knowledge.
Murphys law-like entropy - dominates in the absence of targeted countervailing action-which requires finances.
But failure to translate biotech advances into market realities via agreements with other companies just continued the financial stranglehold-leaving the petri plates as the only financial lifeline.
The CEO's heart attack and slow down are part of the Murphys law mix-last we knew he was back in action fulfilling petri plate orders. I don't know whether he is the only one fulfilling patented petri plate orders or not - does anybody know?
As I've said before over 90% of startups fail to break through into the land of financial viability. Imo they did an excellent job in trying to create income streams-including via patent filing in numerous EU countries in order to license the petri plates there - but despite publishing of such patents etc in the key EU wide publication there apparently were no takers.
Breaking into existing supplier relationships is very difficult. NNLX's double doctorate patent attorney and CEO both donated a substantial amount of time is my guess.
If I remember right NNLX and any company in this no mans land also faces restrictions in the form of PR's- which is possibly one of the reasons we haven't heard anything official for some time.
https://www.otcmarkets.com/stock/NNLX/overview
So, we are still stuck in no mans land-the expert market -where brokers are not allowed to display bids and asks without an updated 211 form-which would require that regulators are satisfied with any updated data -of which there has been none to my knowledge.
Murphys law-like entropy - dominates in the absence of targeted countervailing action-which requires finances.
But failure to translate biotech advances into market realities via agreements with other companies just continued the financial stranglehold-leaving the petri plates as the only financial lifeline.
The CEO's heart attack and slow down are part of the Murphys law mix-last we knew he was back in action fulfilling petri plate orders. I don't know whether he is the only one fulfilling patented petri plate orders or not - does anybody know?
As I've said before over 90% of startups fail to break through into the land of financial viability. Imo they did an excellent job in trying to create income streams-including via patent filing in numerous EU countries in order to license the petri plates there - but despite publishing of such patents etc in the key EU wide publication there apparently were no takers.
Breaking into existing supplier relationships is very difficult. NNLX's double doctorate patent attorney and CEO both donated a substantial amount of time is my guess.
If I remember right NNLX and any company in this no mans land also faces restrictions in the form of PR's- which is possibly one of the reasons we haven't heard anything official for some time.
https://www.otcmarkets.com/stock/NNLX/overview
(0)
(0)Scroll down for more posts ▼
